問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Nuclear Medicine

Division of General Internal Medicine

Division of Hematology & Oncology

Division of Neurology

Division of Radiology

更新時間:2023-09-19

顏若芳YEN, RUOH-FANG
  • Principal Investigator
  • Clinical Trial Experience (year) -13 years -4 個月

篩選

List

42Cases

2016-12-31 - 2023-12-31

Phase III

A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
  • Condition/Disease

    Prodromal Alzheimer's Disease

  • Test Drug

    Solanezumab (LY2062430)

Participate Sites
10Sites

Terminated9Sites

1 2 3 4 5